Efficacy of Larotrectinib (LOXO-101) in Adult and Pediatric TRK Fusion Cancers
David Michael Hyman, MD of Memorial Sloan-Kettering gives an overview his presentation, which focuses on the efficacy of larotrectinib (LOXO-101) in adult and pediatric TRK fusion cancers at the 2017 ...
Author: ASCO2017
Added: 06/06/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts